PFE

Pfizer Inc

29.39

Nov 06 • 3:59 PM ET -0.49 (-1.64%)

29.35

Aftermarket • 7:59 PM ET -0.04 (-0.13%)

Healthcare Drug Manufacturers - General USA Large NYSE

Nov 06, 9:31 AMPfizer’s $0.43 ex-dividend adjustment and pharma weakness drive Friday’s 3.65% opening decline

Peers: GSK AZN BMY MRK SNY NVS ABBV JNJ AMGN LLY

| Held by: VTI VOO IVV SPY VTV XLV HDV HDV VYM DVY

Scroll to Statements

Index	S&P 500
Market Cap	167.52B
Enterprise Value	216.22B
Income	4.03B
Sales	63.62B
Book/sh	15.61
Cash/sh	2.50
Dividend Est.	1.72 (5.86%)
Dividend TTM	1.72 (5.85%)
Dividend Ex-Date	Nov 06, 2026
Dividend Gr. 3/5Y	2.23% 2.37%
Payout	126.85%
Employees	75000
IPO	Jan 17, 1944

P/E	42.03
Forward P/E	9.99
PEG	-
P/S	2.63
P/B	1.88
P/C	11.74
P/FCF	14.21
EV/EBITDA	9.40
EV/Sales	3.40
Quick Ratio	1.10
Current Ratio	1.42
Debt/Eq	0.70
LT Debt/Eq	0.67
Option/Short	Yes / Yes

EPS (ttm)	0.70
EPS next Y	2.94
EPS next Q	0.69
EPS this Y	-5.76%
EPS next Y	-3.05%
EPS next 5Y	-8.37%
EPS past 3/5Y	-37.19% -3.57%
Sales past 3/5Y	-14.56% 8.48%
EPS Y/Y TTM	-58.96%
Sales Y/Y TTM	1.34%
EPS Q/Q	-9.04%
Sales Q/Q	-0.43%
Earnings	Nov 03 BMO
EPS/Sales Surpr.	18.29% 4.61%

Insider Own	0.09%
Insider Trans	2.18%
Inst Own	69.45%
Inst Trans	-0.74%
ROA	1.95%
ROE	4.44%
ROIC	2.71%
Gross Margin	65.10%
Oper. Margin	25.95%
Profit Margin	6.34%
SMA20	-1.23%
SMA50	2.25%
SMA200	9.23%
Trades

Shs Outstand	5.70B
Shs Float	5.69B
Short Float	2.42%
Short Ratio	4.04
Short Interest	137.82M
52W High	31.44 -6.52%
52W Low	23.62 24.43%
Volatility	3.60% 2.21%
ATR (14)	0.76
RSI (14)	49.51
Beta	0.30
Rel Volume	1.42
Avg Volume	34.11M
Volume	48,319,621

Perf Week	-3.70%
Perf Month	5.64%
Perf Quarter	8.65%
Perf Half Y	14.45%
Perf YTD	18.03%
Perf Year	18.27%
Perf 3Y	-5.74%
Perf 5Y	-39.54%
Perf 10Y	3.37%
Recom	2.60
Target Price	30.07
Prev Close	29.88
Price	29.39
Change %	-1.64%

Consensus

Hold

Avg. Price Target

$30.07

Implied Upside

+2.3%

Analysts15incl. previous ratings

Rating Distribution3 Buy · 10 Hold · 2 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Nov 06, 2026	Downgrade	DDZ Bank	Buy → Hold
Jul 06, 2026	Downgrade	HHSBC Securities	Buy → Hold	$28	-4.7%
Jun 10, 2026	Upgrade	RRBC Capital Mkts	Underperform → Sector Perform	$25	-14.9%
Mar 02, 2026	Upgrade	AArgus	Hold → Buy	$35	+19.1%
Feb 25, 2026	Initiated	RRBC Capital Mkts	Underperform	$25	-14.9%
Feb 20, 2026	Initiated	BBarclays	Underweight	$25	-14.9%
Feb 12, 2026	Downgrade	DDaiwa Securities	Outperform → Neutral	$27	-8.1%
Jan 07, 2026	Resumed	UUBS	Neutral	$25	-14.9%
Dec 02, 2025	Resumed	CCitigroup	Neutral	$26	-11.5%
Nov 13, 2025	Initiated	BScotiabank	Sector Outperform	$30	+2.1%
Apr 22, 2025	Initiated	CCantor Fitzgerald	Neutral	$24	-18.3%
Dec 10, 2024	Resumed	BBofA Securities	Neutral	$29	-1.3%
Nov 15, 2024	Initiated	WWolfe Research	Underperform	$25	-14.9%
Oct 25, 2024	Resumed	CCitigroup	Neutral	$30	+2.1%
Oct 17, 2024	Initiated	BBernstein	Mkt Perform	$32	+8.9%
Aug 07, 2024	Upgrade	DDaiwa Securities	Neutral → Outperform
Mar 22, 2024	Downgrade	AArgus	Buy → Hold
Feb 23, 2024	Initiated	GGuggenheim	Buy	$36	+22.5%
Jan 04, 2024	Downgrade	TTD Cowen	Outperform → Market Perform	$32	+8.9%
Oct 20, 2023	Resumed	UUBS	Neutral	$36 → $34	+15.7%

Nov-06-26 10:00AM	Pfizer to build $650M manufacturing technology center in Connecticut (Manufacturing Dive)
09:27AM	CFOs On the Move: Week ending Nov. 6 (CFO.com)
Nov-04-26 07:45AM	The Market Loves the Democrat Sweep. It's More Complicated for AI Stocks. (Barrons.com)
05:30AM	Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity Market (Barrons.com)
Nov-03-26 04:40PM	Earnings live updates: Duolingo stock jumps on user growth, upbeat guidance (Yahoo Finance)
04:15PM	Loading…
04:15PM	Pfizer CEO on outlook for monthly GLP-1 injection coming to market (CNBC TV)
03:50PM	Pfizer Beats And Raises Again As Launch Growth Accelerates, But 2027 Patent Cliff Still Shadows The Rally (Earnings Whispers)
02:28PM	Pfizer CEO Says No Big Deals for Now (The Wall Street Journal)
01:30PM	Pfizer earnings analysis: questions answered and next catalysts (Investing.com)
11:31AM	Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher (PR Newswire)
10:01AM	Apple stock falls, chip stocks rebound as oil extends decline: AlphaCheck (Yahoo Finance)
10:00AM	Pfizer promotes insider to CFO (CFO Dive)
09:37AM	Q3 Earnings & JOLTS Report on Midterm Voting Day (Zacks)
09:12AM	Pfizer earnings beat estimates as drugmaker raises 2026 outlook (Proactive)
08:29AM	Pfizer Hikes Guidance On Solid Third Quarter, Names Company Vet As New CFO (Investor's Business Daily)
07:22AM	Loading…
07:22AM	Pfizer increases annual profit forecast amid solid demand for blood thinner drug (Investing.com)
07:20AM	Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates (Barrons.com)
06:53AM	Pfizer: Q3 Earnings Snapshot (Associated Press)
06:45AM	Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance (Business Wire)
06:40AM	Pfizer Appoints Cecile Guegan as Chief Financial Officer (Business Wire)
04:29AM	Advanced Micro heads another batch of tech earnings (MarketWatch)
03:30AM	Stock Market Today: Dow, S&P 500 and Nasdaq to decline as U.S. midterm elections loom; AMD results on tap; Apple stock lower after results (MarketWatch)
Nov-01-26 10:52PM	Stocktwits Pharma Pulse: Biotech Beats The Broader Market Novo, Pfizer And Moderna Earnings Up Next (Stocktwits)
09:06AM	What To Expect In Markets This Week: AAPL, PLTR, AMD, SMCI, SHOP, Earnings, Jobs Report And More (Stocktwits)
Oct-29-26 11:54AM	Looking for income? These dividend stocks have high yields that seem well supported. (MarketWatch)
Oct-28-26 10:21AM	After Wegovy and Zepbound, 6 weight-loss drugs in development (Quartz)
09:27AM	Lilly shuffles business structure; Novartis writes off part of Avidity deal (BioPharma Dive)
Oct-27-26 09:26AM	Medicus Pharma CEO to present precision oncology progress at global biotech conferences (Proactive)
09:00AM	Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot. (Barrons.com)
06:45AM	Pfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma (Business Wire)
05:22PM	Loading…
Oct-26-26 05:22PM	Pfizer Rallies Into Third Quarter As Whisper Bets Cost Cuts Can Offset Shrinking COVID Sales (Earnings Whispers)
01:41PM	Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting (Business Wire)
12:07PM	Werner Buys 49% of Fisher Brothers 605 Third Avenue Tower (CRE Daily)
09:26AM	Nuvectis Reports Complete Brain Tumor Responses as Big Pharma Pays Billions for Cancer Drugs (NASDAQ: NVCT) (FinanceWire)
09:23AM	Nasdaq-Listed Solana Company Gains Strategic Enterprise Status in Hong Kong (CryptoProwl)
Oct-24-26 11:18AM	Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 (Business Wire)
Oct-23-26 04:09AM	U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AI (Barrons.com)
Oct-22-26 01:29PM	Biohaven Stock Heads for Best Day in 3 Years as FDA Agrees to Review Drug Again (Barrons.com)
12:24PM	Biohavens previously rejected rare disease drug to get fresh FDA review (BioPharma Dive)
11:58AM	How To Boost The Dividend Yield On This Drugmaking Behemoth (Investor's Business Daily)
Oct-20-26 06:03PM	Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors (Exec Edge)
02:53PM	Wall Street rises with investors rotating into healthcare and value stocks (Reuters)
Oct-17-26 12:15PM	Pfizer or Kraft Heinz: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
Oct-16-26 10:57PM	What Was Eli Lilly Telling You Before Its Stock Ran? (Trefis)
08:53PM	When Amgen's Forecast And Chart Say The Same Thing, Pay Attention (Trefis)
08:37PM	Gileads HIV Prevention Business Just Topped $1 Billion A Quarter. What Comes Next? (Trefis)
08:13PM	Is Amgen Stock Increasing Your Market Risk? (Trefis)
10:44AM	What Is The Case For Waiting On Moderna Stock? (Trefis)
Oct-15-26 03:59PM	Better Dividend Stock: Pfizer vs. GSK (TIKR)
03:46PM	How Has Merck's Story Changed? (Trefis)
09:09AM	Where Could Johnson & Johnson's Next Growth Come From? (Trefis)
05:30AM	Big Pharma Is Pouring Billions Into a New Class of 'Protein Degrader' Drugs (The Wall Street Journal)
Oct-14-26 11:47PM	Why Did GME, BMBL, PFE Stocks Hit 52-Week Highs Today? (Stocktwits)
09:47PM	How Much Downside Is Left In Liquidia Stock? (Trefis)
05:45PM	What Could Send Regeneron Stock Higher? (Trefis)
03:34PM	Better High-Yield Dividend Stock: Pfizer vs. General Mills (TIKR)
03:25PM	Better High-Yield Dividend Stock: Pfizer vs. British American Tobacco (TIKR)
03:12PM	Better High-Yield Dividend Stock: Pfizer vs. UPS (TIKR)
03:01PM	Better High-Yield Dividend Stock: Pfizer vs. Healthpeak (TIKR)
02:40PM	Better High-Yield Dividend Stock: Pfizer vs. Edison International (TIKR)
02:34PM	Better High-Yield Dividend Stock: Pfizer vs. Clorox (TIKR)
09:31AM	J&J earnings set negative tone; Shkreli vs. the FTC (BioPharma Dive)
08:18AM	The Open Question Under Johnson & Johnson Stock's Price (Trefis)
06:45AM	Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026 (Business Wire)
06:39AM	Pfizer partners with Enodia Therapeutics in $500m drug deal (Pharmaceutical Business Review)
Oct-13-26 07:48PM	Is Amgen Stock Worth More Than Its Competitors? (Trefis)
04:20PM	Pfizer or Enbridge: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
03:59PM	What Does Bristol-Myers Squibb Offer That Pfizer Does Not? (Trefis)
03:24PM	What Is Eli Lilly Stock's Biggest Opportunity? (Trefis)
03:00AM	Ozempic face powers revival of a fading British giant (The Telegraph)
Oct-12-26 05:01PM	Where Could Moderna's Next Growth Come From? (Trefis)
10:15AM	Bristol Myers Stock Is Rising on a Double Dose of Good News (Barrons.com)
Oct-11-26 09:22PM	SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH (Stocktwits)
Oct-10-26 12:06PM	Four Analysts Raised Their Pfizer Targets in One Week Without an Upgrade. Heres Where the Stock Could Go By 2030 (TIKR)
Oct-09-26 08:47PM	Why Is Everyone Ignoring Gilead Stock's High Cash Yield? (Trefis)
08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits)
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
03:39PM	Top Research Reports for JPMorgan, ASML & Chevron (Zacks)
02:12PM	Does The Move In Merck Stock Change Anything? (Trefis)
12:14PM	Moderna stock jumps on planned national cancer vaccine effort (Yahoo Finance)
11:18AM	FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts (BioPharma Dive)
Oct-08-26 08:36PM	Should You Be Worried About Pfizer Stock? (Trefis)
08:19PM	What Is Going On With Regeneron Stock? (Trefis)
09:35AM	PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer (Stocktwits)
09:04AM	Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances (Proactive)
09:03AM	What Would It Take For Amgen Stock To Move Higher? (Trefis)
07:07AM	FDA approves Pfizer's Tukysa regimen for metastatic breast cancer (Pharmaceutical Business Review)
Oct-07-26 07:14PM	Is Exelixis Stock Engineered To Make You Money? (Trefis)
12:57PM	Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer (Business Wire)
12:13PM	Why You Should Think About Eli Lilly Stock Differently Now (Trefis)
Oct-06-26 07:30PM	Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 (PR Newswire)
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
10:00AM	Pfizer Declares Fourth-Quarter 2026 Dividend (Business Wire)
08:44AM	Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results (Quartz)
01:38AM	Pfizers $6.49 Billion Prevnar Franchise Faces a New Challenger (TIKR)
Oct-05-26 02:37PM	PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit Blue-Sky Case (Stocktwits)
02:18PM	Drug stocks show rare weakness amid fears of vaccine competition (MarketWatch)
10:43AM	Vaxcyte Soars 36% on Phase 3 Pneumococcal Vaccine Win That Sets a New Benchmark (TIKR)
10:39AM	Vaxcytes stock up after pneumococcal vaccine proves non-inferiority (Clinical Trials Arena)
10:32AM	Vaxcyte shares surge on late-stage vaccine trial success (Proactive)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Aug 12 '26	Buy	26.34	38,000	1,000,920	429,173	Aug 12 04:04 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 05 '26	Sale	25.40	3,278	83,261	28,611	Aug 06 11:26 AM
BLAYLOCK RONALD E	Director	Aug 05 '26	Buy	25.46	39,231	998,821	66,938	Aug 05 04:03 PM
Buckley Mortimer J	Director	Aug 05 '26	Buy	25.52	37,632	960,369	37,632	Aug 05 04:02 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Interim CFO & Executive VPMs. Cecile Guegan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your Finviz experience